Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Preclinical assessment of topical treatments of herpes simplex virus infection: 5% (E)-5-(2-bromovinyl)-2′-deoxyuridine cream — Donna Freeman (1985) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Preclinical assessment of topical treatments of herpes simplex virus infection: 5% (E)-5-(2-bromovinyl)-2′-deoxyuridine cream
Shared by
De Clercq Erik
KU Leuven
Preclinical assessment of topical treatments of herpes simplex virus infection: 5% (E)-5-(2-bromovinyl)-2′-deoxyuridine cream
Article
1985
en
Authors
+1 more
DF
Donna Freeman
SS
Stephen L. Sacks
De Clercq Erik
KU Leuven
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1984
Topical treatment of cutaneous herpes simplex virus infection in hairless mice with (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds
De Clercq Erik
Article
1981
Efficacy of (E)-5-(2-bromovinyl)-2?-deoxyuridine in the topical treatment of herpes simplex keratitis
P. C. Maudgal
,
L Missotten
,
De Clercq Erik
,
J Descamps
,
E. Meuter
Article
1982
Treatment of experimental herpes simplex virus encephalitis with (E)-5-(2-bromovinyl)-2'-deoxyuridine in mice
De Clercq Erik
,
Z X Zhang
,
Iain S. Sim
Article
1982
Chemotherapeutic Efficacy of E-5-(2-Bromovinyl)-2'-Deoxyuridine for Orofacial Infection with Herpes Simplex Virus Type 1 in Mice
N.- H. Park
,
Deborah Pavan‐Langston
,
Hélène Boisjoly
,
De Clercq Erik
Article
1984
Metabolic fate of (E)-5-(2-bromovinyl)-2'-deoxyuridine in herpes simplex virus- and mock-infected cells
Nana K. Ayisi
,
De Clercq Erik
,
Richard A. Wall
,
H. D. Hughes
,
Stephen L. Sacks
Discussion(0)
No comments yet. Be the first to comment.